Quantcast
Last updated on April 19, 2014 at 7:50 EDT

Latest Sanofi US Stories

2014-02-04 12:28:20

First and only medicine in its class approved for over-the-counter use that provides 24 hour relief of the full range of nasal allergy symptoms including nasal congestion BRIDGEWATER, N.J., Feb. 4, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and its U.S. consumer healthcare division Chattem announced today that Nasacort(®) Allergy 24HR Nasal Spray is now available over-the-counter (OTC) in the U.S. to relieve the full range of seasonal and year-round nasal allergy...

2013-12-09 12:25:18

Developing approaches for involving patients in drug development BRIDGEWATER, N.J., Dec. 9, 2013 /PRNewswire/ -- Today, Sanofi US launched its second Partners in Patient Health (PiPH) Innovation Challenge: Collaborate | Innovate, which will award $100,000 to the winning team. This year's theme is "Co-Creating for Breakthroughs: Moving toward a collaborative research and development ecosystem." The Challenge calls on non-profit patient, provider and professional associations to partner with...

2013-09-04 16:27:45

BRIDGEWATER, N.J. and CHAPEL HILL, N.J., Sept. 4, 2013 /PRNewswire/ -- Sanofi US (NYSE: SNY) and POZEN Inc. (NASDAQ: POZN) announced the signing of an exclusive license agreement for the commercialization of POZEN's proprietary, investigational, coordinated-delivery tablets combining immediate-release omeprazole, a proton pump inhibitor (PPI), and enteric-coated (EC) aspirin in a single tablet ("PA"), PA8140 and PA32540. Under the terms of the agreement, Sanofi will have exclusive...

2013-08-20 08:29:51

- Majority of Survey Respondents Reported They or Their Child Experienced a Severe Allergic Reaction While Traveling - BRIDGEWATER, N.J., Aug. 20, 2013 /PRNewswire/ -- In a new nationwide survey* commissioned by Sanofi US, the makers of Auvi-Q(TM) (epinephrine injection, USP), 65% of caregivers of children with a severe allergy to food, insect stings or other causes reported that their child has had a severe allergic reaction while on vacation. The nationwide survey, conducted by Wakefield...

2013-06-22 16:20:18

BRIDGEWATER, N.J. and BOSTON, June 22, 2013 /PRNewswire/ -- Sanofi US collaborated with Joslin Diabetes Center on a successful, multicultural outreach pilot that was overseen and funded by Sanofi US with Joslin as its partner in providing clinical and behavioral educational materials and training based on their award-winning On the Road diabetes program. The pilot, which was implemented in four ethnically diverse cities across the United States, demonstrated a significant reduction in...

2013-06-22 12:21:20

-- Lixisenatide decreased HbA1c by reducing PPG when added to basal insulin with or without oral anti-diabetic agents -- BRIDGEWATER, N.J., June 22, 2013 /PRNewswire/ -- Sanofi US (EURONEXT: SAN and NYSE: SNY) announced today data that showed lixisenatide, an investigational once-daily prandial glucagon-like peptide 1 (GLP-1) receptor agonist, decreased HbA1c by reducing PPG (postprandial glucose) daytime exposure when added to standard of care which includes basal insulin with or...

2013-06-04 12:27:32

- Connect & Coach(TM) Awarded $100,000 to Further Develop its Novel Solution to Help Improve Health Outcomes for People Living with Diabetes - BRIDGEWATER, N.J., June 4, 2013 /PRNewswire/ -- Sanofi US announced today that Connect & Coach(TM) has been selected as the winning solution of the 2013 Data Design Diabetes (DDD) Innovation Challenge - Prove It! at Health Datapalooza IV in Washington, DC. Sanofi US will award Connect & Coach(TM) $100,000 to further develop its...

2013-05-16 08:27:49

- Bettis Unveils New Playbook for Defending Against Severe Allergic Reactions and Urges Those Affected to Take Action - BRIDGEWATER, N.J., May 16, 2013 /PRNewswire/ -- Professional football icon Jerome Bettis and Sanofi US, the makers of Auvi-Q(TM) (epinephrine injection, USP), have teamed up to raise awareness about severe allergic reactions (anaphylaxis) and introduce The Severe Allergy & Anaphylaxis Playbook - a collection of tips to help educate people living with severe...

2013-05-06 08:26:11

-Donation to Diabetes Hands Foundation Doubled When Documentary Reaches 10,000 Views- BRIDGEWATER, N.J., May 6, 2013 /PRNewswire/ -- Sanofi US and Golden Globe and Emmy nominated actress Elizabeth Perkins proudly premiered the Diabetes Co-Stars documentary, "Strength in Numbers," at the American Diabetes Association Expo in Los Angeles, CA this past weekend. The film, produced by Elizabeth and her 'co-star' and husband Julio Macat, features her diabetes story as well as two other...

2013-04-11 08:28:42

Over-the-Counter Allergy Brand Now Offers Topical Relief for Itchy, Dry Skin Just in Time for Summer BRIDGEWATER, N.J., April 11, 2013 /PRNewswire/ -- Allegra Anti-Itch Cooling Relief Cream and Allegra Anti-Itch Intensive Relief Cream are now available in drug, grocery and mass merchandiser stores nationwide. Chattem, Inc., the Consumer Healthcare Division of Sanofi US and the makers of Allegra Allergy, introduced the Anti-Itch Creams to its family of products to help provide itch...